354 related articles for article (PubMed ID: 32517455)
1. [Predictors for the Bronchiolitis Obliterans Syndrome in Lung Transplant Patient].
Yang S; Abuduwufuer A; Lv W; Bao F; Hu J
Zhongguo Fei Ai Za Zhi; 2020 Jun; 23(6):496-502. PubMed ID: 32517455
[TBL] [Abstract][Full Text] [Related]
2. Lung transplantation: does oxidative stress contribute to the development of bronchiolitis obliterans syndrome?
Madill J; Aghdassi E; Arendt B; Hartman-Craven B; Gutierrez C; Chow CW; Allard J;
Transplant Rev (Orlando); 2009 Apr; 23(2):103-10. PubMed ID: 19298941
[TBL] [Abstract][Full Text] [Related]
3. Ischemia-reperfusion injury after lung transplantation increases risk of late bronchiolitis obliterans syndrome.
Fiser SM; Tribble CG; Long SM; Kaza AK; Kern JA; Jones DR; Robbins MK; Kron IL
Ann Thorac Surg; 2002 Apr; 73(4):1041-7; discussion 1047-8. PubMed ID: 11996238
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and outcome of bronchiolitis obliterans syndrome after lung transplantation. Washington University Lung Transplant Group.
Sundaresan S; Trulock EP; Mohanakumar T; Cooper JD; Patterson GA
Ann Thorac Surg; 1995 Nov; 60(5):1341-6; discussion 1346-7. PubMed ID: 8526624
[TBL] [Abstract][Full Text] [Related]
5. Blood CD9
Brosseau C; Danger R; Durand M; Durand E; Foureau A; Lacoste P; Tissot A; Roux A; Reynaud-Gaubert M; Kessler R; Mussot S; Dromer C; Brugière O; Mornex JF; Guillemain R; Claustre J; Magnan A; Brouard S;
Am J Transplant; 2019 Nov; 19(11):3162-3175. PubMed ID: 31305014
[TBL] [Abstract][Full Text] [Related]
6. Bronchiolitis obliterans syndrome: incidence, natural history, prognosis, and risk factors.
Heng D; Sharples LD; McNeil K; Stewart S; Wreghitt T; Wallwork J
J Heart Lung Transplant; 1998 Dec; 17(12):1255-63. PubMed ID: 9883768
[TBL] [Abstract][Full Text] [Related]
7. Parametric Response Mapping of Bronchiolitis Obliterans Syndrome Progression After Lung Transplantation.
Verleden SE; Vos R; Vandermeulen E; Ruttens D; Bellon H; Heigl T; Van Raemdonck DE; Verleden GM; Lama V; Ross BD; Galbán CJ; Vanaudenaerde BM
Am J Transplant; 2016 Nov; 16(11):3262-3269. PubMed ID: 27367568
[TBL] [Abstract][Full Text] [Related]
8. The Role of TGF-β in the Association Between Primary Graft Dysfunction and Bronchiolitis Obliterans Syndrome.
DerHovanessian A; Weigt SS; Palchevskiy V; Shino MY; Sayah DM; Gregson AL; Noble PW; Palmer SM; Fishbein MC; Kubak BM; Ardehali A; Ross DJ; Saggar R; Lynch JP; Elashoff RM; Belperio JA
Am J Transplant; 2016 Feb; 16(2):640-9. PubMed ID: 26461171
[TBL] [Abstract][Full Text] [Related]
9. Bronchiolitis obliterans following lung transplantation.
Al-Githmi I; Batawil N; Shigemura N; Hsin M; Lee TW; He GW; Yim A
Eur J Cardiothorac Surg; 2006 Dec; 30(6):846-51. PubMed ID: 17055283
[TBL] [Abstract][Full Text] [Related]
10. Bronchiolitis obliterans: pathogenesis, prevention, and management.
Paradis I
Am J Med Sci; 1998 Mar; 315(3):161-78. PubMed ID: 9519929
[TBL] [Abstract][Full Text] [Related]
11. Increased plasma mannose binding lectin levels are associated with bronchiolitis obliterans after lung transplantation.
Budd SJ; Aris RM; Medaiyese AA; Tilley SL; Neuringer IP
Respir Res; 2012 Jul; 13(1):56. PubMed ID: 22762710
[TBL] [Abstract][Full Text] [Related]
12. A review of bronchiolitis obliterans syndrome and therapeutic strategies.
Hayes D
J Cardiothorac Surg; 2011 Jul; 6():92. PubMed ID: 21767391
[TBL] [Abstract][Full Text] [Related]
13. Early bronchiolitis obliterans syndrome shows an abnormality of perfusion not ventilation in lung transplant recipients.
Thompson BR; Ellis MJ; Stuart-Andrews C; Lopez M; Kedarisetty S; Snell GI; Prisk GK
Respir Physiol Neurobiol; 2015 Sep; 216():28-34. PubMed ID: 25981891
[TBL] [Abstract][Full Text] [Related]
14. Proteomic bronchiolitis obliterans syndrome risk monitoring in lung transplant recipients.
Wolf T; Oumeraci T; Gottlieb J; Pich A; Brors B; Eils R; Haverich A; Schlegelberger B; Welte T; Zapatka M; von Neuhoff N
Transplantation; 2011 Aug; 92(4):477-85. PubMed ID: 21716170
[TBL] [Abstract][Full Text] [Related]
15. Decreased serum and bronchoalveolar lavage levels of Clara cell secretory protein (CC16) is associated with bronchiolitis obliterans syndrome and airway neutrophilia in lung transplant recipients.
Nord M; Schubert K; Cassel TN; Andersson O; Riise GC
Transplantation; 2002 Apr; 73(8):1264-9. PubMed ID: 11981419
[TBL] [Abstract][Full Text] [Related]
16. Advances in Understanding Bronchiolitis Obliterans After Lung Transplantation.
Verleden SE; Sacreas A; Vos R; Vanaudenaerde BM; Verleden GM
Chest; 2016 Jul; 150(1):219-25. PubMed ID: 27212132
[TBL] [Abstract][Full Text] [Related]
17. Lung transplantation. Bronchiolitis obliterans syndrome.
Corris PA
Chest Surg Clin N Am; 2003 Aug; 13(3):543-57. PubMed ID: 13678312
[TBL] [Abstract][Full Text] [Related]
18. Is transplant operation important in determining posttransplant risk of bronchiolitis obliterans syndrome in lung transplant recipients?
Hadjiliadis D; Davis RD; Palmer SM
Chest; 2002 Oct; 122(4):1168-75. PubMed ID: 12377838
[TBL] [Abstract][Full Text] [Related]
19. Bronchiolitis obliterans syndrome: the final frontier for lung transplantation.
Todd JL; Palmer SM
Chest; 2011 Aug; 140(2):502-508. PubMed ID: 21813529
[TBL] [Abstract][Full Text] [Related]
20. Immune mechanisms in the pathogenesis of bronchiolitis obliterans syndrome after lung transplantation.
Jaramillo A; Fernández FG; Kuo EY; Trulock EP; Patterson GA; Mohanakumar T
Pediatr Transplant; 2005 Feb; 9(1):84-93. PubMed ID: 15667618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
